Medexus Pharmaceuticals Inc. (MEDXF)
| Previous Close | 2.1900 |
| Open | 2.1100 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 2.1000 - 2.1300 |
| 52 Week Range | 1.5400 - 7.7600 |
| Volume | |
| Avg. Volume | 16,964 |
| Market Cap | 41.317M |
| Beta (5Y Monthly) | 1.15 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.1230 |
| Earnings Date | Feb. 28, 2022 - Mar. 04, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.00 |
- Baystreet
Stocks in play: Medexus Pharmaceuticals Inc.
Announced that CEO Ken d’Entremont, and Chief Financial Officer Marcel Konrad will be presenting at ...
- GlobeNewswire
Medexus to Present at the H.C. Wainwright BioConnect 2022 Conference
TORONTO and CHICAGO, Jan. 07, 2022 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSX: MDP) (OTCQX: MEDXF) today announced that Ken d’Entremont, Chief Executive Officer of Medexus, and Marcel Konrad, Chief Financial Officer of Medexus, will be presenting at the H.C. Wainwright BioConnect 2022 Conference being held virtually January 10-13, 2022. Medexus’ presentation will be available on-demand to registered attendees via the conference platform beginning Monday, J
- ACCESSWIRE
Sidoti December Micro Cap Virtual Conference
Presentation Times Released for 75+ Presenting CompaniesWednesday and Thursday, December 8-9, 2021NEW YORK, NY / ACCESSWIRE / December 7, 2021 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day December Micro Cap Virtual Conference taking place Wednesday and Thursday, December 8 - 9, 2021. The links can also be found at www.
